Ratings BIO-key International, Inc.

Equities

BKYI

US09060C5076

Delayed Nasdaq 03:59:57 2024-03-28 pm EDT 5-day change 1st Jan Change
2.1 USD 0.00% Intraday chart for BIO-key International, Inc. +11.70% -30.00%

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The company shows low valuation levels, with an enterprise value at 0.32 times its sales.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company has insufficient levels of profitability.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Electronic Equipment & Parts

1st Jan change Capi. Investor Rating ESG Refinitiv
-30.00% 3.8M -
-19.77% 1.7B -
+141.12% 133M - -
+14.39% 122M -
+26.76% 86.72M - -
-38.95% 59.83M -
C-
+8.77% 51.64M - -
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes